▽Astellas Pharma Inc. ●02/06 15:45 Financial Results for Q3 YTD/FY2024We announced our financial results for Q3 YTD/FY2024 on February 4th. Presentation material, video, and meeting script are available.View moreRead moreFeb 05, 2025Press ReleasesAstellas Submits New Drug Application for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in JapanFeb 05, 2025Press ReleasesRecording of Extraordinary Losses in No